New appointment at TerrAscend
TerrAscend Corp. announced on Thursday the appointment of Matthew J. Johnson as president of TerrAscend Corporation and TerrAscend USA, effective immediately.
November 29, 2018 By Grow Opportunity Staff
In this senior executive role, Johnson will be responsible for leading TerrAscend’s newly-formed U.S. operations. Michael Nashat will continue in his role as the company’s chief executive officer.
“I am thrilled to have Matt, a senior-level pharmaceutical executive, join TerrAscend’s leadership team,” Nashat stated in a release. “We look forward to working with him as we implement our significant growth plans.”
Johnson, a seasoned healthcare industry executive with over 25 years of experience, has held multiple senior-level positions with several large medical device and pharmaceutical companies including AbbVie, a company with $28 billion in 2017 revenue, which was spun-out of Abbott Laboratories in 2013. Most recently, he led the AbbVie Transition Office and was responsible for managing enterprise-wide transformation efforts, including merger integration.
Prior to this, he headed Global Alliance Management within Abbott’s pharmaceuticals division where he drove collaboration strategy planning, alignment and communication among project teams for all of Abbott’s partnered pipeline products. Johnson’s Abbott expertise also includes merger, acquisition and licensing for Abbott’s global pharmaceuticals business, where he led new market initiatives and business development opportunities.
Additional senior level experience includes P&L management, operations in mature and emerging international markets, business development, marketing and finance, attained while serving in leadership roles with Brunswick Corporation and Baxter Healthcare Corporation.
Johnson earned an MBA degree with honours from the Kellogg Graduate School of Management, Northwestern University, and a BA degree in economics from the University of Vermont.
“Matt is a significant addition to the TerrAscend team as we execute and build a leading international cannabis company,” Jason Wild, chairman of TerrAscend stated. “His extensive experience successfully executing multi-billion dollar M&A transactions and leading their complex integrations is crucial as we expand into the U.S. cannabis market.”
Print this page